HUANG JAMES purchased 17.6% of their position (55.57K shares) of CASI PHARMACEUTICALS, INC (DE) on the open market
Open‑market purchase worth $229.7K — a significant purchase. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 9/8/2022ACC: 0000899243-22-030690
+55.57K
Net shares
Net buyer
$229.7K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
55.57K acquired
Non-Derivative Transactions3
Common Stock
Indirect
Shares
+19.16K
Price / share
$3.89
Trade value
$74.60K
% of position
6.1%
9/6/2022
315.94K→335.11K
Common Stock
Indirect
Shares
+3.11K
Price / share
$4.00
Trade value
$12.43K
% of position
0.9%
9/7/2022
335.11K→338.22K
Common Stock
Indirect
Shares
+33.30K
Price / share
$4.28
Trade value
$142.63K
% of position
9.8%
9/8/2022
338.22K→371.52K
Total
Net shares
+55.57K
Net value
$229.66K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/6/2022 | P · Purchase | +19.16K | $3.89 | $74.60K | 6.1% | 315.94K | 335.11K |
| Common Stock Indirect | 9/7/2022 | P · Purchase | +3.11K | $4.00 | $12.43K | 0.9% | 335.11K | 338.22K |
| Common Stock Indirect | 9/8/2022 | P · Purchase | +33.30K | $4.28 | $142.63K | 9.8% | 338.22K | 371.52K |
| Total | +55.57K | $229.66K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned191.00
Total
191.00 direct191.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 191.00 | Direct |
| Total | 191.00 | 191.00 direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported